Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (561-570 of 850) with videos related to

Pageof 85
Sort By:
World Journal of Urology|August 26, 2021
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomyLuigi Nocera, Mike Wenzel, Claudia Collà Ruvolo, et al.
Npj Imaging|July 3, 2025
Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology imagesOkyaz Eminaga, Fred Saad, Zhe Tian, et al.
Annals of Surgical Oncology|October 19, 2010
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based studyLars Budäus, Maxine Sun, Firas Abdollah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancerSarah Minner, Birte Jessen, Lars Stiedenroth, et al.
International Journal of Cancer|April 25, 2007
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European menAndrea Gallina, Pierre I Karakiewicz, Georg C Hutterer, et al.
Cancer|September 8, 2011
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United StatesQuoc-Dien Trinh, Jan Schmitges, Maxine Sun, et al.
European Urology Focus|January 22, 2025
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic TreatmentFabian Falkenbach, Flemming Lischewski, Sophie Knipper, et al.
European Urology|June 4, 2015
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at PresentationPrasanna Sooriakumaran, Jeffrey Karnes, Christian Stief, et al.
International Journal of Molecular Sciences|April 21, 2015
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomyMaria Christina Tsourlakis, Puya Khosrawi, Philipp Weigand, et al.
Frontiers in Surgery|March 11, 2022
Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Lukas Hohenhorst, et al.
Pageof 85

Showing results (561-570 of 850) with videos related to

Sort By:
Pageof 85
World Journal of Urology|August 26, 2021
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomyLuigi Nocera, Mike Wenzel, Claudia Collà Ruvolo, et al.
Npj Imaging|July 3, 2025
Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology imagesOkyaz Eminaga, Fred Saad, Zhe Tian, et al.
Annals of Surgical Oncology|October 19, 2010
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based studyLars Budäus, Maxine Sun, Firas Abdollah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancerSarah Minner, Birte Jessen, Lars Stiedenroth, et al.
International Journal of Cancer|April 25, 2007
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European menAndrea Gallina, Pierre I Karakiewicz, Georg C Hutterer, et al.
Cancer|September 8, 2011
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United StatesQuoc-Dien Trinh, Jan Schmitges, Maxine Sun, et al.
European Urology Focus|January 22, 2025
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic TreatmentFabian Falkenbach, Flemming Lischewski, Sophie Knipper, et al.
European Urology|June 4, 2015
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at PresentationPrasanna Sooriakumaran, Jeffrey Karnes, Christian Stief, et al.
International Journal of Molecular Sciences|April 21, 2015
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomyMaria Christina Tsourlakis, Puya Khosrawi, Philipp Weigand, et al.
Frontiers in Surgery|March 11, 2022
Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Lukas Hohenhorst, et al.
Pageof 85